DET1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.437730E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.173800E-01 |
Normal-vs-Stage2 |
2.879200E-03 |
Normal-vs-Stage3 |
5.7678000042749E-08 |
Normal-vs-Stage4 |
1.98719999999764E-06 |
Stage1-vs-Stage2 |
2.346300E-02 |
Stage1-vs-Stage3 |
3.43170000194348E-08 |
Stage1-vs-Stage4 |
3.93830000000595E-06 |
Stage2-vs-Stage3 |
9.882500E-02 |
Stage2-vs-Stage4 |
1.752420E-01 |
Stage3-vs-Stage4 |
9.349800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.43490000000946E-05 |
Normal-vs-AfricanAmerican |
6.838400E-02 |
Normal-vs-Asian |
4.350000E-01 |
Caucasian-vs-AfricanAmerican |
4.622800E-01 |
Caucasian-vs-Asian |
5.931800E-01 |
AfricanAmerican-vs-Asian |
8.382400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.64419999999699E-05 |
Normal-vs-Female |
2.201800E-02 |
Male-vs-Female |
5.734200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.397000E-01 |
Normal-vs-Age(41-60Yrs) |
5.661600E-03 |
Normal-vs-Age(61-80Yrs) |
9.68230000000236E-05 |
Normal-vs-Age(81-100Yrs) |
1.879130E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.179200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.582200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.646300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.380400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.573200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.705600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.748400E-02 |
Normal-vs-Grade 2 |
2.402200E-01 |
Normal-vs-Grade 3 |
1.37349999995706E-06 |
Normal-vs-Grade 4 |
1.27159949236955E-10 |
Grade 1-vs-Grade 2 |
3.356100E-02 |
Grade 1-vs-Grade 3 |
5.58809999999799E-05 |
Grade 1-vs-Grade 4 |
2.80660000018251E-07 |
Grade 2-vs-Grade 3 |
1.09599999997823E-06 |
Grade 2-vs-Grade 4 |
6.74519995413903E-10 |
Grade 3-vs-Grade 4 |
2.523000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.901200E-01 |
Normal-vs-ccB subtype |
3.9602000000416E-06 |
ccA subtype-vs-ccB subtype |
1.64943999999556E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.800280E-03 |
Normal-vs-N1 |
3.59650000000267E-05 |
N0-vs-N1 |
2.676100E-02 |
|
|